Education
About Us
Working with TipRanks
Follow Us
Keymed Biosciences, Inc. (HK:2162)
:2162
Comparison Results
Ascletis Pharma, Inc.
HK$10.68
HK$10.88B
―
968.00%
1 Buy
1 Hold
0 Sell
Moderate Buy
Simcere Pharmaceutical Group Limited
HK$12.86
HK$33.95B
33.89
109.79%
1 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$7.65
HK$14.22B
―
161.09%
0 Buy
0 Hold
0 Sell
Hold
CARsgen Therapeutics Holdings Ltd.
HK$21.06
HK$12.13B
―
588.24%
0 Buy
0 Hold
1 Sell
Moderate Sell
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$27.50
HK$9.88B
76.44
342.83%
0 Buy
0 Hold
0 Sell
Hold
Performance Comparison
HK:2162
Keymed Biosciences, Inc.
72.10
33.40
86.30%
HK:1672
Ascletis Pharma, Inc.
10.68
9.68
968.00%
HK:2096
Simcere Pharmaceutical Group Limited
12.86
6.71
109.11%
HK:2157
Lepu Biopharma Co. Ltd. Class H
7.65
4.55
146.77%
HK:2171
CARsgen Therapeutics Holdings Ltd.
21.06
18.00
588.24%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
27.50
21.20
336.51%